Tech Company Financing Transactions
Slingshot Biosciences Funding Round
Slingshot Biosciences closed a $11 million Series A funding round on 2/6/2023. Investors included Arch Venture Partners and Anterra Capital.
Transaction Overview
Company Name
Announced On
2/6/2023
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
Arch Venture Partners (Lead Investor) (Corey Ritter)
Proceeds Purpose
The company intends to use the funds to accelerate the commercialization of its technology for cell and gene therapies, and further develop its adoptive cell therapy and therapeutics platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1250 45th St. 330
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
We're a group of creative thinkers who are trying to democratize and change Drug Development (DD) and Diagnostics (Dx).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Kim
VP - Bus. Development
Anh Nguyen
VP - Engineering
Brandon Miller
Browse more venture capital transactions:
Prev: 2/6/2023: Simple HealthKit venture capital transaction
Next: 2/6/2023: Elementus venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs